Rice Hall James & Associates LLC Buys 30,756 Shares of Maximus, Inc. $MMS

Rice Hall James & Associates LLC grew its stake in Maximus, Inc. (NYSE:MMS) by 16.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 213,995 shares of the health services provider’s stock after acquiring an additional 30,756 shares during the period. Rice Hall James & Associates LLC owned 0.39% of Maximus worth $18,472,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of MMS. Royal Bank of Canada grew its holdings in shares of Maximus by 146.2% in the 1st quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock valued at $1,345,000 after acquiring an additional 11,716 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Maximus by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock valued at $2,351,000 after acquiring an additional 221 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Maximus by 7.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock valued at $12,321,000 after acquiring an additional 11,754 shares in the last quarter. Jane Street Group LLC lifted its stake in Maximus by 941.2% in the 1st quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock valued at $6,701,000 after purchasing an additional 88,835 shares during the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in Maximus in the 2nd quarter valued at about $204,000. Institutional investors own 97.21% of the company’s stock.

Maximus Trading Down 1.8%

Shares of NYSE:MMS opened at $61.19 on Tuesday. The company has a 50-day simple moving average of $63.44 and a 200 day simple moving average of $75.68. The company has a debt-to-equity ratio of 0.87, a quick ratio of 2.21 and a current ratio of 2.21. The company has a market capitalization of $3.21 billion, a P/E ratio of 9.16 and a beta of 0.58. Maximus, Inc. has a 52-week low of $56.92 and a 52-week high of $100.00.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.98 by $0.09. The firm had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.32 billion. Maximus had a net margin of 7.02% and a return on equity of 25.10%. The business’s revenue for the quarter was down 4.1% compared to the same quarter last year. During the same period last year, the business posted $2.01 earnings per share. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Sell-side analysts forecast that Maximus, Inc. will post 8.43 earnings per share for the current year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were given a dividend of $0.33 per share. The ex-dividend date was Friday, May 15th. This represents a $1.32 annualized dividend and a yield of 2.2%. Maximus’s dividend payout ratio (DPR) is 19.76%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Zacks Research downgraded shares of Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Wall Street Zen upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research note on Saturday, June 6th. Finally, Weiss Ratings downgraded shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock has an average rating of “Hold”.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.